X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
0
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-27-2021-1635324993.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-8-2019-1557294096.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-17-2018-1539751948.pdf
https://www.pharmacompass.com/pdf/news/gattex-teduglutide-amlodipine-and-valsartan-tabs-shire-nps-pharm-v-par-pharma-et-al-1533038693.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203499
https://www.thehindubusinessline.com/companies/zydus-cadila-gets-usfda-nod-to-market-4-generic-products/article24450730.ece
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206928
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-22-2017-1490161550.pdf
http://www.fiercepharma.com/manufacturing/mylan-extends-recall-as-stray-tablets-diabetes-med-show-up-bottles-antidepressant
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-8-2017-1488980224.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-1-2017-1488363970.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-22-2017-1487758756.pdf
http://www.fiercepharma.com/manufacturing/teva-recalls-half-million-units-diabetes-drug-made-patheon
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204720
http://www.fiercepharma.com/pharma/doj-s-price-fixing-investigation-could-lead-to-sizable-liabilities-analyst-says
http://www.pharma-excipients.ch/2016/11/10/formulation-development-of-glipizide-matrix-tablet-using-different-proportion-of-natural-and-semi-synthetic-polymers/
http://www.fiercepharma.com/manufacturing/endo-s-par-recalls-half-a-million-birth-control-pills-made-by-patheon
http://www.pharma-excipients.ch/2016/05/08/controlled-release-matrix-tablets-of-glipizide-influence-of-differentgrades-of-ethocel-and-co-excipient-on-drug-release/
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0436-2015&w=04152015&lang=eng
Market Place
Share 
